TONYA DAVIS: Open Payments
NPI 1306581335 · MANCHESTER, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,274 in 56 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $249 · 2025 $1,274
Food & beverage: $1,053Education: $221
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 19 | $490 |
| E.R. Squibb & Sons, L.L.C. | 7 | $195 |
| Alkermes, Inc. | 11 | $159 |
| ABBVIE INC. | 6 | $148 |
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
| Janssen Pharmaceuticals, Inc | 4 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| Lundbeck LLC | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: COBENFY, VRAYLAR, AUSTEDO XR, UZEDY, REXULTI, ARISTADA, INVEGA SUSTENNA, FANAPT.
Industry payments across CT — which companies pay providers there.
